Skip to main content
SpringerLink
Log in

High cumulative exposure to oral corticosteroids for asthma a concern

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. AstraZeneca provided funding for the study.

Reference

  • Hew M, et al. Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia. Medical Journal of Australia : 9 Sep 2020. Available from: URL: http://doi.org/10.5694/mja2.50758

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

High cumulative exposure to oral corticosteroids for asthma a concern. Reactions Weekly 1823, 7 (2020). https://doi.org/10.1007/s40278-020-83635-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-83635-x

Search

Navigation